| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | peptide lactyltransferase (CoA-dependent) activity | 1.75e-05 | 2 | 84 | 2 | GO:0120300 | |
| GeneOntologyMolecularFunction | histone H3K27 acetyltransferase activity | 1.75e-05 | 2 | 84 | 2 | GO:0044017 | |
| GeneOntologyMolecularFunction | histone modifying activity | 5.10e-05 | 229 | 84 | 7 | GO:0140993 | |
| GeneOntologyMolecularFunction | histone H3K18 acetyltransferase activity | 5.23e-05 | 3 | 84 | 2 | GO:0043993 | |
| GeneOntologyMolecularFunction | acyltransferase activity, transferring groups other than amino-acyl groups | 6.50e-05 | 238 | 84 | 7 | GO:0016747 | |
| GeneOntologyMolecularFunction | nuclear androgen receptor binding | 3.58e-04 | 33 | 84 | 3 | GO:0050681 | |
| GeneOntologyMolecularFunction | tau protein binding | 9.57e-04 | 46 | 84 | 3 | GO:0048156 | |
| GeneOntologyMolecularFunction | acetyltransferase activity | 9.73e-04 | 104 | 84 | 4 | GO:0016407 | |
| GeneOntologyMolecularFunction | transcription factor binding | 1.22e-03 | 753 | 84 | 10 | GO:0008134 | |
| GeneOntologyMolecularFunction | histone acetyltransferase activity | 1.29e-03 | 51 | 84 | 3 | GO:0004402 | |
| GeneOntologyMolecularFunction | transforming growth factor beta receptor activity | 1.32e-03 | 13 | 84 | 2 | GO:0005024 | |
| GeneOntologyMolecularFunction | transcription coactivator binding | 1.53e-03 | 54 | 84 | 3 | GO:0001223 | |
| GeneOntologyMolecularFunction | AP-2 adaptor complex binding | 1.54e-03 | 14 | 84 | 2 | GO:0035612 | |
| GeneOntologyMolecularFunction | peptide-lysine-N-acetyltransferase activity | 1.61e-03 | 55 | 84 | 3 | GO:0061733 | |
| GeneOntologyMolecularFunction | histone H3 acetyltransferase activity | 1.77e-03 | 15 | 84 | 2 | GO:0010484 | |
| GeneOntologyMolecularFunction | peptide N-acetyltransferase activity | 2.07e-03 | 60 | 84 | 3 | GO:0034212 | |
| GeneOntologyMolecularFunction | transmembrane receptor protein serine/threonine kinase activity | 3.16e-03 | 20 | 84 | 2 | GO:0004675 | |
| GeneOntologyMolecularFunction | C-acyltransferase activity | 3.49e-03 | 21 | 84 | 2 | GO:0016408 | |
| GeneOntologyMolecularFunction | peroxisome proliferator activated receptor binding | 3.49e-03 | 21 | 84 | 2 | GO:0042975 | |
| GeneOntologyMolecularFunction | BMP binding | 3.82e-03 | 22 | 84 | 2 | GO:0036122 | |
| GeneOntologyMolecularFunction | chromatin binding | 3.84e-03 | 739 | 84 | 9 | GO:0003682 | |
| GeneOntologyMolecularFunction | ATP-dependent activity | 4.28e-03 | 614 | 84 | 8 | GO:0140657 | |
| GeneOntologyMolecularFunction | N-acetyltransferase activity | 4.35e-03 | 78 | 84 | 3 | GO:0008080 | |
| GeneOntologyBiologicalProcess | T-tubule organization | 5.57e-06 | 9 | 85 | 3 | GO:0033292 | |
| GeneOntologyBiologicalProcess | positive regulation of nuclear-transcribed mRNA poly(A) tail shortening | 2.38e-05 | 14 | 85 | 3 | GO:0060213 | |
| GeneOntologyBiologicalProcess | regulation of nuclear-transcribed mRNA poly(A) tail shortening | 3.64e-05 | 16 | 85 | 3 | GO:0060211 | |
| GeneOntologyBiologicalProcess | positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay | 3.64e-05 | 16 | 85 | 3 | GO:1900153 | |
| GeneOntologyBiologicalProcess | canonical NF-kappaB signal transduction | 6.51e-05 | 330 | 85 | 8 | GO:0007249 | |
| GeneOntologyBiologicalProcess | N-terminal peptidyl-lysine acetylation | 1.00e-04 | 4 | 85 | 2 | GO:0018076 | |
| GeneOntologyCellularComponent | Gtr1-Gtr2 GTPase complex | 9.75e-05 | 4 | 85 | 2 | GO:1990131 | |
| GeneOntologyCellularComponent | extrinsic component of synaptic vesicle membrane | 1.40e-04 | 25 | 85 | 3 | GO:0098850 | |
| GeneOntologyCellularComponent | mCRD-mediated mRNA stability complex | 2.43e-04 | 6 | 85 | 2 | GO:0106002 | |
| GeneOntologyCellularComponent | extrinsic component of organelle membrane | 7.12e-04 | 43 | 85 | 3 | GO:0031312 | |
| GeneOntologyCellularComponent | exocytic vesicle membrane | 8.21e-04 | 179 | 85 | 5 | GO:0099501 | |
| GeneOntologyCellularComponent | synaptic vesicle membrane | 8.21e-04 | 179 | 85 | 5 | GO:0030672 | |
| HumanPheno | Prominent forehead | TTC7A JARID2 EDAR WNT5A EDARADD NSD1 ALDH18A1 ITGA3 SRCAP CREBBP EP300 POLR3A | 3.93e-07 | 261 | 40 | 12 | HP:0011220 |
| HumanPheno | Ridged nail | 5.43e-06 | 34 | 40 | 5 | HP:0001807 | |
| HumanPheno | Abnormal nail surface | 1.24e-05 | 40 | 40 | 5 | HP:0025757 | |
| HumanPheno | Aplasia/Hypoplasia of the eyebrow | 3.25e-05 | 216 | 40 | 9 | HP:0100840 | |
| HumanPheno | Plantar crease between first and second toes | 6.01e-05 | 2 | 40 | 2 | HP:0008107 | |
| HumanPheno | Aortic isthmus hypoplasia | 6.01e-05 | 2 | 40 | 2 | HP:0034227 | |
| HumanPheno | High axial triradius | 6.01e-05 | 2 | 40 | 2 | HP:0001042 | |
| HumanPheno | Avascular necrosis of the capital femoral epiphysis | 7.71e-05 | 30 | 40 | 4 | HP:0005743 | |
| HumanPheno | Oligodontia | 1.35e-04 | 65 | 40 | 5 | HP:0000677 | |
| HumanPheno | Sparse eyebrow | 1.43e-04 | 151 | 40 | 7 | HP:0045075 | |
| HumanPheno | Nail dysplasia | 1.56e-04 | 264 | 40 | 9 | HP:0002164 | |
| HumanPheno | Laryngeal cartilage malformation | 1.79e-04 | 3 | 40 | 2 | HP:0008752 | |
| HumanPheno | Phobia | 1.79e-04 | 3 | 40 | 2 | HP:5200232 | |
| HumanPheno | Agoraphobia | 1.79e-04 | 3 | 40 | 2 | HP:0000756 | |
| HumanPheno | Humoral immunodeficiency | 1.79e-04 | 3 | 40 | 2 | HP:0005363 | |
| HumanPheno | Prominent nasal septum | 1.79e-04 | 3 | 40 | 2 | HP:0005322 | |
| HumanPheno | Hypohidrotic ectodermal dysplasia | 1.79e-04 | 3 | 40 | 2 | HP:0007607 | |
| HumanPheno | Radial deviation of thumb terminal phalanx | 1.79e-04 | 3 | 40 | 2 | HP:0005895 | |
| HumanPheno | Anhidrosis | 1.99e-04 | 38 | 40 | 4 | HP:0000970 | |
| HumanPheno | Premature thelarche | 2.83e-04 | 17 | 40 | 3 | HP:0010314 | |
| HumanPheno | Juvenile aseptic necrosis | 3.23e-04 | 43 | 40 | 4 | HP:0100323 | |
| HumanPheno | Trichiasis | 3.57e-04 | 4 | 40 | 2 | HP:0001128 | |
| HumanPheno | Visceral hemangioma | 3.57e-04 | 4 | 40 | 2 | HP:0410266 | |
| HumanPheno | Periorbital hyperpigmentation | 3.57e-04 | 4 | 40 | 2 | HP:0001106 | |
| HumanPheno | Talon cusp | 3.57e-04 | 4 | 40 | 2 | HP:0011087 | |
| HumanPheno | Widened distal phalanges | 3.57e-04 | 4 | 40 | 2 | HP:0006200 | |
| HumanPheno | Vascular ring | 3.57e-04 | 4 | 40 | 2 | HP:0010775 | |
| HumanPheno | Hepatic hemangioma | 3.57e-04 | 4 | 40 | 2 | HP:0031207 | |
| HumanPheno | Hypoplasia of teeth | 3.91e-04 | 126 | 40 | 6 | HP:0000685 | |
| HumanPheno | Anodontia | 3.98e-04 | 19 | 40 | 3 | HP:0000674 | |
| HumanPheno | Abnormality of primary teeth | 4.04e-04 | 82 | 40 | 5 | HP:0006481 | |
| HumanPheno | Advanced eruption of teeth | 4.20e-04 | 46 | 40 | 4 | HP:0006288 | |
| HumanPheno | Absent earlobe | 4.66e-04 | 20 | 40 | 3 | HP:0000387 | |
| HumanPheno | Retrognathia | JARID2 BIN1 WNT5A RNF113A RTTN NSD1 SRCAP CREBBP EP300 POLR3A | 4.74e-04 | 375 | 40 | 10 | HP:0000278 |
| HumanPheno | Sparse hair | TTC7A EDAR DSG1 EDARADD RNF113A NSD1 ALDH18A1 ITGA3 CREBBP POLR3A | 5.61e-04 | 383 | 40 | 10 | HP:0008070 |
| HumanPheno | Periorbital wrinkles | 5.92e-04 | 5 | 40 | 2 | HP:0000607 | |
| HumanPheno | Papillary cystadenoma of the epididymis | 5.92e-04 | 5 | 40 | 2 | HP:0009715 | |
| HumanPheno | Supernumerary cusp | 5.92e-04 | 5 | 40 | 2 | HP:0033777 | |
| HumanPheno | Epididymal neoplasm | 5.92e-04 | 5 | 40 | 2 | HP:0030421 | |
| HumanPheno | Broad thumb | 6.22e-04 | 90 | 40 | 5 | HP:0011304 | |
| HumanPheno | Abnormal foramen magnum morphology | 7.13e-04 | 23 | 40 | 3 | HP:0002699 | |
| HumanPheno | Agenesis of permanent teeth | 7.13e-04 | 23 | 40 | 3 | HP:0006349 | |
| HumanPheno | Abnormality of hair density | TTC7A EDAR DSG1 EDARADD RNF113A NSD1 ALDH18A1 ITGA3 CREBBP POLR3A | 7.61e-04 | 398 | 40 | 10 | HP:0011357 |
| HumanPheno | Dislocated radial head | 7.77e-04 | 54 | 40 | 4 | HP:0003083 | |
| HumanPheno | Everted upper lip vermilion | 8.10e-04 | 24 | 40 | 3 | HP:0010803 | |
| HumanPheno | Abnormal fingertip morphology | 8.75e-04 | 203 | 40 | 7 | HP:0001211 | |
| HumanPheno | Large foramen magnum | 8.84e-04 | 6 | 40 | 2 | HP:0002700 | |
| MousePheno | small heart | TTC7A JARID2 TGFBR3 CAMK1D WNT5A RTTN CACNA1I ATP2A2 CREBBP NEURL4 EP300 | 7.89e-07 | 321 | 73 | 11 | MP:0002188 |
| MousePheno | ventricular hypoplasia | 1.26e-05 | 99 | 73 | 6 | MP:0000279 | |
| MousePheno | abnormal myocardium compact layer morphology | 2.54e-05 | 67 | 73 | 5 | MP:0004056 | |
| MousePheno | abnormal duvet hair morphology | 2.69e-05 | 2 | 73 | 2 | MP:0000407 | |
| MousePheno | absent duvet hair | 2.69e-05 | 2 | 73 | 2 | MP:0000408 | |
| MousePheno | increased circulating HDL cholesterol level | 3.25e-05 | 238 | 73 | 8 | MP:0001556 | |
| MousePheno | ventricle myocardium hypoplasia | 3.37e-05 | 71 | 73 | 5 | MP:0010502 | |
| MousePheno | abnormal cardiac muscle tissue morphology | PLIN4 JARID2 TGFBR3 BIN1 BMPR2 DSG2 SGPL1 QKI ATP2A2 CREBBP EP300 | 4.29e-05 | 489 | 73 | 11 | MP:0010630 |
| MousePheno | abnormal myocardium layer morphology | 5.46e-05 | 414 | 73 | 10 | MP:0005329 | |
| MousePheno | abnormal heart layer morphology | 6.41e-05 | 422 | 73 | 10 | MP:0010545 | |
| MousePheno | myocardium hypoplasia | 8.47e-05 | 86 | 73 | 5 | MP:0010500 | |
| MousePheno | thin ventricle myocardium compact layer | 1.46e-04 | 20 | 73 | 3 | MP:0010556 | |
| MousePheno | absent zigzag hairs | 1.60e-04 | 4 | 73 | 2 | MP:0006366 | |
| MousePheno | abnormal vasculogenesis | 1.78e-04 | 54 | 73 | 4 | MP:0001622 | |
| MousePheno | heart hypoplasia | 1.99e-04 | 103 | 73 | 5 | MP:0002740 | |
| MousePheno | abnormal heart size | TTC7A PRSS54 JARID2 TGFBR3 CAMK1D DSG2 KIF26B WNT5A RTTN CACNA1I QKI ATP2A2 CREBBP NEURL4 EP300 PLCE1 | 3.15e-04 | 1180 | 73 | 16 | MP:0005406 |
| MousePheno | abnormal ventricle myocardium morphology | 3.46e-04 | 116 | 73 | 5 | MP:0010499 | |
| Domain | INT_SG_DDX_CT_C | 5.19e-06 | 8 | 86 | 3 | PF15300 | |
| Domain | INT_SG_DDX_CT_C | 5.19e-06 | 8 | 86 | 3 | IPR029307 | |
| Domain | Nuc_rcpt_coact_CREBbp | 2.10e-05 | 2 | 86 | 2 | IPR014744 | |
| Domain | HAT_KAT11 | 2.10e-05 | 2 | 86 | 2 | PF08214 | |
| Domain | KIX | 2.10e-05 | 2 | 86 | 2 | PS50952 | |
| Domain | ZnF_TAZ | 2.10e-05 | 2 | 86 | 2 | SM00551 | |
| Domain | CBP_P300_HAT | 2.10e-05 | 2 | 86 | 2 | IPR031162 | |
| Domain | DUF902 | 2.10e-05 | 2 | 86 | 2 | PF06001 | |
| Domain | - | 2.10e-05 | 2 | 86 | 2 | 1.20.1020.10 | |
| Domain | RING_CBP-p300 | 2.10e-05 | 2 | 86 | 2 | IPR010303 | |
| Domain | - | 2.10e-05 | 2 | 86 | 2 | 1.10.1630.10 | |
| Domain | Creb_binding | 2.10e-05 | 2 | 86 | 2 | PF09030 | |
| Domain | - | 2.10e-05 | 2 | 86 | 2 | 1.10.246.20 | |
| Domain | zf-TAZ | 2.10e-05 | 2 | 86 | 2 | PF02135 | |
| Domain | ZF_TAZ | 2.10e-05 | 2 | 86 | 2 | PS50134 | |
| Domain | Histone_AcTrfase_Rtt109/CBP | 2.10e-05 | 2 | 86 | 2 | IPR013178 | |
| Domain | KAT11 | 2.10e-05 | 2 | 86 | 2 | SM01250 | |
| Domain | Znf_TAZ | 2.10e-05 | 2 | 86 | 2 | IPR000197 | |
| Domain | KIX_dom | 2.10e-05 | 2 | 86 | 2 | IPR003101 | |
| Domain | KIX | 2.10e-05 | 2 | 86 | 2 | PF02172 | |
| Domain | CBP_P300_HAT | 2.10e-05 | 2 | 86 | 2 | PS51727 | |
| Domain | C2 | 3.15e-05 | 131 | 86 | 6 | PF00168 | |
| Domain | C2 | 4.05e-05 | 137 | 86 | 6 | SM00239 | |
| Domain | C2 | 4.96e-05 | 142 | 86 | 6 | PS50004 | |
| Domain | RmlC_Cupin | 5.05e-05 | 16 | 86 | 3 | IPR011051 | |
| Domain | - | 6.24e-05 | 148 | 86 | 6 | 2.60.40.150 | |
| Domain | C2_dom | 1.10e-04 | 164 | 86 | 6 | IPR000008 | |
| Domain | Desmoglein | 1.25e-04 | 4 | 86 | 2 | IPR009123 | |
| Domain | Gtr1_RagA | 1.25e-04 | 4 | 86 | 2 | PF04670 | |
| Domain | Gtr1_RagA | 1.25e-04 | 4 | 86 | 2 | IPR006762 | |
| Domain | FerI | 2.08e-04 | 5 | 86 | 2 | SM01202 | |
| Domain | FerB | 2.08e-04 | 5 | 86 | 2 | SM01201 | |
| Domain | Ferlin_B-domain | 2.08e-04 | 5 | 86 | 2 | IPR012561 | |
| Domain | PolyA | 2.08e-04 | 5 | 86 | 2 | SM00517 | |
| Domain | Ferlin_C | 2.08e-04 | 5 | 86 | 2 | PF16165 | |
| Domain | Ferlin_C | 2.08e-04 | 5 | 86 | 2 | IPR032362 | |
| Domain | FerIin_dom | 2.08e-04 | 5 | 86 | 2 | IPR012968 | |
| Domain | FerI | 2.08e-04 | 5 | 86 | 2 | PF08151 | |
| Domain | FerB | 2.08e-04 | 5 | 86 | 2 | PF08150 | |
| Domain | - | 2.08e-04 | 5 | 86 | 2 | 1.10.1900.10 | |
| Domain | PABP | 2.08e-04 | 5 | 86 | 2 | PF00658 | |
| Domain | PABC | 2.08e-04 | 5 | 86 | 2 | PS51309 | |
| Domain | PABP_1234 | 2.08e-04 | 5 | 86 | 2 | IPR006515 | |
| Domain | PABP_HYD | 2.08e-04 | 5 | 86 | 2 | IPR002004 | |
| Domain | Nuc_rcpt_coact | 3.11e-04 | 6 | 86 | 2 | IPR009110 | |
| Domain | Desmosomal_cadherin | 4.34e-04 | 7 | 86 | 2 | IPR009122 | |
| Domain | ZZ | 3.06e-03 | 18 | 86 | 2 | PF00569 | |
| Domain | ZF_ZZ_2 | 3.06e-03 | 18 | 86 | 2 | PS50135 | |
| Domain | ZF_ZZ_1 | 3.06e-03 | 18 | 86 | 2 | PS01357 | |
| Domain | Znf_ZZ | 3.41e-03 | 19 | 86 | 2 | IPR000433 | |
| Domain | ZnF_ZZ | 3.41e-03 | 19 | 86 | 2 | SM00291 | |
| Pathway | REACTOME_RORA_ACTIVATES_GENE_EXPRESSION | 7.27e-05 | 18 | 65 | 3 | M26942 | |
| Pathway | BIOCARTA_EIF4_PATHWAY | 1.55e-04 | 23 | 65 | 3 | MM1470 | |
| Pathway | BIOCARTA_PELP1_PATHWAY | 2.07e-04 | 5 | 65 | 2 | MM1575 | |
| Pathway | REACTOME_NFE2L2_REGULATING_INFLAMMATION_ASSOCIATED_GENES | 2.07e-04 | 5 | 65 | 2 | M48020 | |
| Pathway | REACTOME_NFE2L2_REGULATING_ER_STRESS_ASSOCIATED_GENES | 2.07e-04 | 5 | 65 | 2 | M48023 | |
| Pathway | REACTOME_LRR_FLII_INTERACTING_PROTEIN_1_LRRFIP1_ACTIVATES_TYPE_I_IFN_PRODUCTION | 2.07e-04 | 5 | 65 | 2 | M27228 | |
| Pathway | REACTOME_PRE_NOTCH_EXPRESSION_AND_PROCESSING | 2.17e-04 | 119 | 65 | 5 | M607 | |
| Pathway | WP_PATHWAYS_AFFECTED_IN_ADENOID_CYSTIC_CARCINOMA | 2.26e-04 | 65 | 65 | 4 | M39682 | |
| Pathway | REACTOME_TGFBR3_EXPRESSION | 2.82e-04 | 28 | 65 | 3 | M48253 | |
| Pathway | BIOCARTA_PELP1_PATHWAY | 3.10e-04 | 6 | 65 | 2 | M22062 | |
| Pathway | BIOCARTA_PPARG_PATHWAY | 4.33e-04 | 7 | 65 | 2 | MM1573 | |
| Pathway | REACTOME_RUNX1_REGULATES_TRANSCRIPTION_OF_GENES_INVOLVED_IN_DIFFERENTIATION_OF_MYELOID_CELLS | 4.33e-04 | 7 | 65 | 2 | M27799 | |
| Pathway | BIOCARTA_PPARG_PATHWAY | 5.76e-04 | 8 | 65 | 2 | M22058 | |
| Pathway | REACTOME_NFE2L2_REGULATING_MDR_ASSOCIATED_ENZYMES | 5.76e-04 | 8 | 65 | 2 | M48022 | |
| Pathway | REACTOME_REGULATION_OF_NFE2L2_GENE_EXPRESSION | 5.76e-04 | 8 | 65 | 2 | M48024 | |
| Pathway | REACTOME_NFE2L2_REGULATES_PENTOSE_PHOSPHATE_PATHWAY_GENES | 5.76e-04 | 8 | 65 | 2 | M46443 | |
| Pubmed | Identification of cancer/testis-antigen genes by massively parallel signature sequencing. | 2.57e-10 | 15 | 87 | 5 | 15905330 | |
| Pubmed | 1.51e-08 | 3 | 87 | 3 | 10347196 | ||
| Pubmed | 6.04e-08 | 4 | 87 | 3 | 11581372 | ||
| Pubmed | Irisin Mediates Effects on Bone and Fat via αV Integrin Receptors. | PLIN4 FASN RBM12 BMP2K SAP18 SPTLC2 SGPL1 PABPC3 WDR20 OSBPL11 ALDH18A1 SRPRA CPSF2 SQOR ATP2A2 PABPC1 EP300 | 9.95e-08 | 1451 | 87 | 17 | 30550785 |
| Pubmed | BIN1 OXCT1 BMP2K SGPL1 PABPC3 CPSF2 SQOR PABPC1 SLC1A3 RPH3A | 1.29e-07 | 430 | 87 | 10 | 32581705 | |
| Pubmed | Network organization of the huntingtin proteomic interactome in mammalian brain. | FASN BIN1 MAP2 BMP2K PABPC3 ZRANB2 PRKCB ATP2A2 PABPC1 SLC1A3 RPH3A | 4.42e-07 | 621 | 87 | 11 | 22794259 |
| Pubmed | 2.38e-06 | 152 | 87 | 6 | 38360978 | ||
| Pubmed | Control of hippocampal morphogenesis and neuronal differentiation by the LIM homeobox gene Lhx5. | 2.46e-06 | 11 | 87 | 3 | 10325223 | |
| Pubmed | 3.12e-06 | 40 | 87 | 4 | 28386764 | ||
| Pubmed | Interaction of tau with the RNA-Binding Protein TIA1 Regulates tau Pathophysiology and Toxicity. | 3.96e-06 | 166 | 87 | 6 | 27160897 | |
| Pubmed | JARID2 MYOF DSG2 BMP2K SGPL1 WDR20 NOL6 ZRANB2 SMC4 NSD1 ALDH18A1 SRPRA CPSF2 SQOR ATP2A2 | 4.28e-06 | 1497 | 87 | 15 | 31527615 | |
| Pubmed | JARID2 DSG2 BMP2K SAP18 SPTLC2 SGPL1 GPAT3 ALDH18A1 SQOR TFDP2 | 4.28e-06 | 634 | 87 | 10 | 34591612 | |
| Pubmed | Interpreting cancer genomes using systematic host network perturbations by tumour virus proteins. | 4.57e-06 | 499 | 87 | 9 | 22810586 | |
| Pubmed | ISG15 Connects Autophagy and IFN-γ-Dependent Control of Toxoplasma gondii Infection in Human Cells. | 5.15e-06 | 268 | 87 | 7 | 33024031 | |
| Pubmed | Mammalian miRNA RISC recruits CAF1 and PABP to affect PABP-dependent deadenylation. | 5.39e-06 | 14 | 87 | 3 | 19716330 | |
| Pubmed | From the Cover: Indispensability of the glutamate transporters GLAST and GLT1 to brain development. | 5.39e-06 | 14 | 87 | 3 | 16880397 | |
| Pubmed | 6.19e-06 | 2 | 87 | 2 | 27881875 | ||
| Pubmed | Molecular characterization of the histone acetyltransferase CREBBP/EP300 genes in myeloid neoplasia. | 6.19e-06 | 2 | 87 | 2 | 34845315 | |
| Pubmed | 6.19e-06 | 2 | 87 | 2 | 19729597 | ||
| Pubmed | 6.19e-06 | 2 | 87 | 2 | 31443490 | ||
| Pubmed | 6.19e-06 | 2 | 87 | 2 | 39287984 | ||
| Pubmed | Identification and Characterization of p300-Mediated Lysine Residues in Cardiac SERCA2a. | 6.19e-06 | 2 | 87 | 2 | 36834924 | |
| Pubmed | 6.19e-06 | 2 | 87 | 2 | 20717166 | ||
| Pubmed | 6.19e-06 | 2 | 87 | 2 | 25893291 | ||
| Pubmed | 6.19e-06 | 2 | 87 | 2 | 11559821 | ||
| Pubmed | 6.19e-06 | 2 | 87 | 2 | 32576962 | ||
| Pubmed | 6.19e-06 | 2 | 87 | 2 | 19822209 | ||
| Pubmed | 6.19e-06 | 2 | 87 | 2 | 24522976 | ||
| Pubmed | Tandem arrangement of the closely linked desmoglein genes on human chromosome 18. | 6.19e-06 | 2 | 87 | 2 | 7790000 | |
| Pubmed | CBP is required for environmental enrichment-induced neurogenesis and cognitive enhancement. | 6.19e-06 | 2 | 87 | 2 | 21847097 | |
| Pubmed | 6.19e-06 | 2 | 87 | 2 | 32850288 | ||
| Pubmed | 6.19e-06 | 2 | 87 | 2 | 10534404 | ||
| Pubmed | p300 or CBP is required for insulin-stimulated glucose uptake in skeletal muscle and adipocytes. | 6.19e-06 | 2 | 87 | 2 | 34813504 | |
| Pubmed | 6.19e-06 | 2 | 87 | 2 | 20301699 | ||
| Pubmed | Novel member of the mouse desmoglein gene family: Dsg1-beta. | 6.19e-06 | 2 | 87 | 2 | 12631242 | |
| Pubmed | 6.19e-06 | 2 | 87 | 2 | 24639469 | ||
| Pubmed | 6.19e-06 | 2 | 87 | 2 | 37816914 | ||
| Pubmed | Binding of p300/CBP co-activators by polyoma large T antigen. | 6.19e-06 | 2 | 87 | 2 | 11438528 | |
| Pubmed | 6.19e-06 | 2 | 87 | 2 | 10918613 | ||
| Pubmed | 6.19e-06 | 2 | 87 | 2 | 35502657 | ||
| Pubmed | 6.19e-06 | 2 | 87 | 2 | 31898871 | ||
| Pubmed | Germline or inducible knockout of p300 or CBP in skeletal muscle does not alter insulin sensitivity. | 6.19e-06 | 2 | 87 | 2 | 30888860 | |
| Pubmed | Exploitation of EP300 and CREBBP Lysine Acetyltransferases by Cancer. | 6.19e-06 | 2 | 87 | 2 | 27881443 | |
| Pubmed | 6.19e-06 | 2 | 87 | 2 | 19272189 | ||
| Pubmed | Nucleotide sequence of a mouse testis poly(A) binding protein cDNA. | 6.19e-06 | 2 | 87 | 2 | 1630930 | |
| Pubmed | Differential contribution of p300 and CBP to regulatory element acetylation in mESCs. | 6.19e-06 | 2 | 87 | 2 | 32690000 | |
| Pubmed | 6.19e-06 | 2 | 87 | 2 | 30953353 | ||
| Pubmed | 6.19e-06 | 2 | 87 | 2 | 21803292 | ||
| Pubmed | Mutations in SRCAP, encoding SNF2-related CREBBP activator protein, cause Floating-Harbor syndrome. | 6.19e-06 | 2 | 87 | 2 | 22265015 | |
| Pubmed | 6.19e-06 | 2 | 87 | 2 | 9811832 | ||
| Pubmed | 6.19e-06 | 2 | 87 | 2 | 24089570 | ||
| Pubmed | 6.19e-06 | 2 | 87 | 2 | 15706485 | ||
| Pubmed | Developmental expression of poly(A) binding protein mRNAs during spermatogenesis in the mouse. | 6.19e-06 | 2 | 87 | 2 | 7893484 | |
| Pubmed | AR coactivators, CBP/p300, are critical mediators of DNA repair in prostate cancer. | 6.19e-06 | 2 | 87 | 2 | 39266679 | |
| Pubmed | 6.19e-06 | 2 | 87 | 2 | 22303793 | ||
| Pubmed | 6.19e-06 | 2 | 87 | 2 | 34732714 | ||
| Pubmed | 6.19e-06 | 2 | 87 | 2 | 7499430 | ||
| Pubmed | Targeting histone acetylation dynamics and oncogenic transcription by catalytic P300/CBP inhibition. | 6.19e-06 | 2 | 87 | 2 | 34019788 | |
| Pubmed | 6.19e-06 | 2 | 87 | 2 | 19020299 | ||
| Pubmed | 6.19e-06 | 2 | 87 | 2 | 15860545 | ||
| Pubmed | 6.19e-06 | 2 | 87 | 2 | 29460469 | ||
| Pubmed | Expression of p300 and CBP is associated with poor prognosis in small cell lung cancer. | 6.19e-06 | 2 | 87 | 2 | 24551300 | |
| Pubmed | 6.19e-06 | 2 | 87 | 2 | 33911074 | ||
| Pubmed | 6.19e-06 | 2 | 87 | 2 | 9018065 | ||
| Pubmed | 6.19e-06 | 2 | 87 | 2 | 24648406 | ||
| Pubmed | 6.19e-06 | 2 | 87 | 2 | 30135524 | ||
| Pubmed | 6.19e-06 | 2 | 87 | 2 | 34502015 | ||
| Pubmed | Distribution of co-activators CBP and p300 during mouse oocyte and embryo development. | 6.19e-06 | 2 | 87 | 2 | 16596650 | |
| Pubmed | The p300 and CBP Transcriptional Coactivators Are Required for β-Cell and α-Cell Proliferation. | 6.19e-06 | 2 | 87 | 2 | 29217654 | |
| Pubmed | 6.19e-06 | 2 | 87 | 2 | 26971890 | ||
| Pubmed | Structural insights into the human GW182-PABC interaction in microRNA-mediated deadenylation. | 6.19e-06 | 2 | 87 | 2 | 20098421 | |
| Pubmed | 6.19e-06 | 2 | 87 | 2 | 10049825 | ||
| Pubmed | CBP/p300 acetyltransferase activity in hematologic malignancies. | 6.19e-06 | 2 | 87 | 2 | 27380996 | |
| Pubmed | CREBBP and p300 lysine acetyl transferases in the DNA damage response. | 6.19e-06 | 2 | 87 | 2 | 29170789 | |
| Pubmed | 6.19e-06 | 2 | 87 | 2 | 21555743 | ||
| Pubmed | CBP/p300 induction is required for retinoic acid sensitivity in human mammary cells. | 6.19e-06 | 2 | 87 | 2 | 12646247 | |
| Pubmed | 6.19e-06 | 2 | 87 | 2 | 26934656 | ||
| Pubmed | 6.19e-06 | 2 | 87 | 2 | 11867645 | ||
| Pubmed | Levels of free PABP are limited by newly polyadenylated mRNA in early Spisula embryogenesis. | 6.19e-06 | 2 | 87 | 2 | 10954604 | |
| Pubmed | Expression of the nuclear coactivators CBP and p300 in developing craniofacial tissue. | 6.19e-06 | 2 | 87 | 2 | 11963968 | |
| Pubmed | 6.19e-06 | 2 | 87 | 2 | 9528808 | ||
| Pubmed | Analysis of genetic stability at the EP300 and CREBBP loci in a panel of cancer cell lines. | 6.19e-06 | 2 | 87 | 2 | 12696060 | |
| Pubmed | 6.19e-06 | 2 | 87 | 2 | 9732454 | ||
| Pubmed | CBP Is Required for Establishing Adaptive Gene Programs in the Adult Mouse Brain. | 6.19e-06 | 2 | 87 | 2 | 36109165 | |
| Pubmed | 6.19e-06 | 2 | 87 | 2 | 12242694 | ||
| Pubmed | 6.19e-06 | 2 | 87 | 2 | 31182547 | ||
| Pubmed | 6.19e-06 | 2 | 87 | 2 | 30635043 | ||
| Pubmed | Phenotype and genotype in 52 patients with Rubinstein-Taybi syndrome caused by EP300 mutations. | 6.19e-06 | 2 | 87 | 2 | 27648933 | |
| Pubmed | 6.19e-06 | 2 | 87 | 2 | 32819890 | ||
| Pubmed | 6.19e-06 | 2 | 87 | 2 | 10610021 | ||
| Pubmed | Emerging roles of p300/CBP in autophagy and autophagy-related human disorders. | 6.19e-06 | 2 | 87 | 2 | 37314181 | |
| Pubmed | Distinct roles for CREB-binding protein and p300 in hematopoietic stem cell self-renewal. | 6.19e-06 | 2 | 87 | 2 | 12397173 | |
| Pubmed | CBP/p300 TAZ1 domain forms a structured scaffold for ligand binding. | 6.19e-06 | 2 | 87 | 2 | 15641773 | |
| Pubmed | 6.19e-06 | 2 | 87 | 2 | 9733868 | ||
| Pubmed | Rubinstein-Taybi syndrome in Chinese population with four novel mutations. | 6.19e-06 | 2 | 87 | 2 | 33063428 | |
| Pubmed | 6.19e-06 | 2 | 87 | 2 | 34506759 | ||
| Pubmed | 6.19e-06 | 2 | 87 | 2 | 22177454 | ||
| Pubmed | 6.19e-06 | 2 | 87 | 2 | 11997580 | ||
| Pubmed | RagA is a functional homologue of S. cerevisiae Gtr1p involved in the Ran/Gsp1-GTPase pathway. | 6.19e-06 | 2 | 87 | 2 | 9394008 | |
| Pubmed | Uncovering a mammalian neural-specific poly(A) binding protein with unique properties. | 6.73e-06 | 15 | 87 | 3 | 37704377 | |
| Interaction | GATA3 interactions | 1.42e-05 | 187 | 85 | 7 | int:GATA3 | |
| Interaction | SLC6A4 interactions | 1.52e-05 | 437 | 85 | 10 | int:SLC6A4 | |
| Interaction | RORA interactions | 2.17e-05 | 39 | 85 | 4 | int:RORA | |
| Cytoband | Ensembl 112 genes in cytogenetic band chrXq26 | 1.95e-05 | 171 | 87 | 5 | chrXq26 | |
| Cytoband | Xq26.3 | 2.88e-04 | 67 | 87 | 3 | Xq26.3 | |
| GeneFamily | Ferlin family | 1.40e-04 | 6 | 56 | 2 | 828 | |
| GeneFamily | Desmosomal cadherins | 1.96e-04 | 7 | 56 | 2 | 1188 | |
| GeneFamily | Zinc fingers ZZ-type|Lysine acetyltransferases | 1.24e-03 | 17 | 56 | 2 | 486 | |
| GeneFamily | Zinc fingers ZZ-type|Lysine acetyltransferases | 1.40e-03 | 18 | 56 | 2 | 91 | |
| Coexpression | HE_LIM_SUN_FETAL_LUNG_C0_MYOFIBROBLAST_1_CELL | 1.14e-07 | 69 | 87 | 6 | M45681 | |
| Coexpression | GSE8621_UNSTIM_VS_LPS_PRIMED_AND_LPS_STIM_MACROPHAGE_DN | 3.35e-07 | 199 | 87 | 8 | M6987 | |
| Coexpression | HE_LIM_SUN_FETAL_LUNG_C0_MYOFIBROBLAST_2_CELL | 1.31e-06 | 104 | 87 | 6 | M45682 | |
| Coexpression | KAECH_NAIVE_VS_MEMORY_CD8_TCELL_UP | 4.73e-06 | 200 | 87 | 7 | M3020 | |
| Coexpression | GSE3565_DUSP1_VS_WT_SPLENOCYTES_POST_LPS_INJECTION_DN | 1.47e-05 | 158 | 87 | 6 | M6333 | |
| Coexpression | GSE27241_WT_VS_RORGT_KO_TH17_POLARIZED_CD4_TCELL_TREATED_WITH_DIGOXIN_UP | 3.07e-05 | 180 | 87 | 6 | M8239 | |
| Coexpression | GSE3920_IFNA_VS_IFNG_TREATED_FIBROBLAST_DN | 3.81e-05 | 187 | 87 | 6 | M6691 | |
| Coexpression | GSE26669_CTRL_VS_COSTIM_BLOCK_MLR_CD8_TCELL_DN | 5.53e-05 | 200 | 87 | 6 | M4667 | |
| Coexpression | GSE9650_NAIVE_VS_MEMORY_CD8_TCELL_UP | 5.53e-05 | 200 | 87 | 6 | M5831 | |
| Coexpression | GSE35685_CD34POS_CD38NEG_VS_CD34POS_CD10NEG_CD62LPOS_BONE_MARROW_DN | 5.53e-05 | 200 | 87 | 6 | M9084 | |
| Coexpression | KAECH_NAIVE_VS_DAY15_EFF_CD8_TCELL_UP | 5.53e-05 | 200 | 87 | 6 | M3014 | |
| Coexpression | KYNG_DNA_DAMAGE_UP | 6.34e-05 | 205 | 87 | 6 | M3961 | |
| Coexpression | MULLIGHAN_NPM1_MUTATED_SIGNATURE_2_UP | 7.41e-05 | 130 | 87 | 5 | M6590 | |
| Coexpression | NUYTTEN_NIPP1_TARGETS_DN | BMPR2 RBM12 BMP2K SPTLC2 PABPC3 OSBPL11 SRPRA ITGA3 ATP2A2 PABPC1 PLCE1 | 1.10e-04 | 845 | 87 | 11 | M18090 |
| Coexpression | BOYLAN_MULTIPLE_MYELOMA_C_D_UP | 1.16e-04 | 143 | 87 | 5 | MM788 | |
| Coexpression | MULLIGHAN_NPM1_SIGNATURE_3_UP | 1.27e-04 | 335 | 87 | 7 | M10277 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_intercalated_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.12e-06 | 174 | 86 | 6 | 5f4436863a40f8bca46e2989bca66c02b6be88d4 | |
| ToppCell | Control-Myeloid-Dendritic_cells|Control / group, cell type (main and fine annotations) | 1.36e-06 | 180 | 86 | 6 | 25ad95c3c30e3b82abe93bd77ba003f5c2241f7c | |
| ToppCell | Immune_cells-large_pre-B.|World / Lineage and Cell class | 1.50e-06 | 183 | 86 | 6 | 81b5ed6ed661d2d6a9b807fefd2f0d59bd4ea77e | |
| ToppCell | facs-Skin-Telogen-3m-Epithelial-Basal_IFE|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.75e-06 | 188 | 86 | 6 | 8cc927b4c51d982fdafa04dc7393617ad9bb220e | |
| ToppCell | COVID-19-Heart-Macrophage|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.81e-06 | 189 | 86 | 6 | 2586f4088721c5debec86c2b211b739fd33713eb | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Immune-Myeloid-Macrophage_Dendritic-M2_Macrophage|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.10e-06 | 194 | 86 | 6 | 1dce6d4b6ac41f80677e3e4c335a4f383bd76f85 | |
| ToppCell | Bronchial-NucSeq-Immune_Myeloid-Mast_cell-Mast_cell|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 2.29e-06 | 197 | 86 | 6 | bed8a9b73af5caee51b1232b31c24a59353658df | |
| ToppCell | Bronchial-NucSeq-Immune_Myeloid-Mast_cell|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 2.29e-06 | 197 | 86 | 6 | b7d5073d44aa1e2cb83ea8d8104c5ed662665755 | |
| ToppCell | Parenchymal-10x3prime_v2-Immune_Myeloid-Myeloid-Megakaryocyte|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 2.50e-06 | 200 | 86 | 6 | 0d76b006d8e8b32174e65e400acd0674354b962c | |
| ToppCell | Parenchymal-10x3prime_v2-Immune_Myeloid-Myeloid|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 2.50e-06 | 200 | 86 | 6 | cc8368665bc6bb7c4f39632ccff07ceaa98a7b65 | |
| ToppCell | droplet-Heart-nan-3m-Hematologic-nan|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.72e-06 | 140 | 86 | 5 | ab90f6f30d89761687f8836e3d327d143ce49ed4 | |
| ToppCell | wk_15-18-Mesenchymal-Myofibro_&_SMC-Myofibro_2|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 1.35e-05 | 157 | 86 | 5 | b9d04ee417c0d8ea0801d10f1c54e138587009fd | |
| ToppCell | VE-mono3|VE / Condition, Cell_class and T cell subcluster | 1.52e-05 | 161 | 86 | 5 | 7df3fefc55ab43b897fc78d1f0c7383b10ac33d5 | |
| ToppCell | VE-mono3-|VE / Condition, Cell_class and T cell subcluster | 1.52e-05 | 161 | 86 | 5 | 4e45bf7eceb0ee30dec4d8852778366776ea5a8f | |
| ToppCell | droplet-Liver-Hepatocytes-24m-Myeloid-Kupffer_cell|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.61e-05 | 163 | 86 | 5 | 8dc0128eeede933537e3bcc5d6ec0322711552f3 | |
| ToppCell | droplet-Liver-Hepatocytes-24m-Myeloid-Kupffer_cell|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.61e-05 | 163 | 86 | 5 | fd243ca223079033be480a24817a399f281fa4d4 | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_intercalated_cell-Outer_Medullary_Collecting_Duct_Intercalated_Cell_Type_A|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.71e-05 | 165 | 86 | 5 | a6c6de17fec678ad0cac3138dde3a14cc39ffd26 | |
| ToppCell | Control-Mast_cells|Control / group, cell type (main and fine annotations) | 1.92e-05 | 169 | 86 | 5 | fdb9abca1d0f4fdc32dd8ac6231651ef34aa5afb | |
| ToppCell | COVID-19-lung-MAST|lung / Disease (COVID-19 only), tissue and cell type | 1.97e-05 | 170 | 86 | 5 | e90f18e5462381b38e918442b38b1c8105291908 | |
| ToppCell | Control-Mast_cells-Mast_cells|Control / group, cell type (main and fine annotations) | 1.97e-05 | 170 | 86 | 5 | c80f6d29096c372da95a8407f402349ff1bb7018 | |
| ToppCell | 3'_v3-lymph-node_spleen-Myeloid_Dendritic-migDC|lymph-node_spleen / Manually curated celltypes from each tissue | 2.09e-05 | 172 | 86 | 5 | 1b24bed3cd8e3fa463c5e7cefdf9e99e639e2f84 | |
| ToppCell | normal_Lymph_Node-Myeloid_cells-CD163+CD14+_DCs|normal_Lymph_Node / Location, Cell class and cell subclass | 2.15e-05 | 173 | 86 | 5 | 38f88f5bbf92a3bf5109bc4782cd071b7cb1ca34 | |
| ToppCell | E16.5-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_airway-SCMF-SCMF_mature|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.27e-05 | 175 | 86 | 5 | 1d8aab491dcc27ea5dbfb6462d18ee280b21a05e | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_intercalated_cell-Cortical_Collecting_Duct_Intercalated_Cell_Type_A|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.27e-05 | 175 | 86 | 5 | 77c16e615c0fb9c83f29d7e0a547be72635fac81 | |
| ToppCell | E16.5-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_airway-SCMF|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.27e-05 | 175 | 86 | 5 | 427a7ee92fe16a90625946492062d37aa0f7235b | |
| ToppCell | COVID-19-lung-MAST|COVID-19 / Disease (COVID-19 only), tissue and cell type | 2.33e-05 | 176 | 86 | 5 | 473c45a381ca109207d66ed1635668b391ea0e1f | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Myeloid-TAM-MG-TAM-MG_prolif-E|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 2.46e-05 | 178 | 86 | 5 | 30d2b54462fd16222ad2e3806be6143e834b29e0 | |
| ToppCell | COVID-19-APC-like|COVID-19 / group, cell type (main and fine annotations) | 2.81e-05 | 183 | 86 | 5 | b8f5afaf9ff1b2b1bc60be58654d1b23859dafa9 | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1-Inh_L2-4_PVALB_C8orf4|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.89e-05 | 184 | 86 | 5 | 2ba98708dfd7f1b2a661578a334684094ff453ad | |
| ToppCell | TCGA-Pancreas-Primary_Tumor-Pancreatic_Adenocarcinoma-Ductal_Adenocarcinoma-1|TCGA-Pancreas / Sample_Type by Project: Shred V9 | 3.04e-05 | 186 | 86 | 5 | 03db813598b67b1e08f759758a1c2023396921fa | |
| ToppCell | droplet-Spleen-nan-3m-Lymphocytic-B_cell|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.20e-05 | 188 | 86 | 5 | 8b1485e63cd4020ba5334a8d4b84725b164549bf | |
| ToppCell | Children_(3_yrs)-Immune-alveolar_macrophage_(MARCO_positive)-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 3.20e-05 | 188 | 86 | 5 | d7a9fb5b021e127b8d927658a55a71098d513b5c | |
| ToppCell | 3'-GW_trimst-2-LargeIntestine-Hematopoietic-B_cells|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.28e-05 | 189 | 86 | 5 | a12ca69eebc88725272c89d71a57fc6ce0c06813 | |
| ToppCell | wk_15-18-Mesenchymal-Myofibro_&_SMC-Myofibro_1|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 3.36e-05 | 190 | 86 | 5 | d24af6af3271e34afab744352afd28be8a7cc5c3 | |
| ToppCell | wk_08-11-Mesenchymal-Myofibro_&_SMC-Myofibro_1|wk_08-11 / Celltypes from embryonic and fetal-stage human lung | 3.36e-05 | 190 | 86 | 5 | 71a00f63fdd4eb4cc6f190d37e7a0417cdaafacb | |
| ToppCell | Monocytes-Tissue-resident_macrophages|Monocytes / Immune cells in Kidney/Urine in Lupus Nephritis | 3.62e-05 | 193 | 86 | 5 | 198552810dcac8d0ca63a78badd6702b49ff6edf | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Immune-Myeloid-Monocytic-Monocyte-derived_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 3.62e-05 | 193 | 86 | 5 | 3e3d7cb3e7242ec9c9677e07e303835649852b52 | |
| ToppCell | Adult-Immune-interstitial_macrophage_(C1Q_positive)|Adult / Lineage, Cell type, age group and donor | 3.62e-05 | 193 | 86 | 5 | 31c0978ba78c9516d498aec0798902e57555e557 | |
| ToppCell | Adult-Immune-interstitial_macrophage_(C1Q_positive)-D231|Adult / Lineage, Cell type, age group and donor | 3.71e-05 | 194 | 86 | 5 | 800d3d7a9e864d2d6a100a4e4af22f45d5790a8d | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Inh_GABAergic|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.71e-05 | 194 | 86 | 5 | 4f758718a1233c25c25d99fc1b7b06f906b8b0a2 | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Inh_GABAergic|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.71e-05 | 194 | 86 | 5 | 02a9cc821c2b14aa7d0e55661a5fab66364474e1 | |
| ToppCell | 367C-Epithelial_cells-Epithelial-B_(AT2)|Epithelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 3.76e-05 | 97 | 86 | 4 | eab10b1af9cd0ce373cd4d0316e0d7b218630584 | |
| ToppCell | 367C-Epithelial_cells-Epithelial-B_(AT2)-|Epithelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 3.76e-05 | 97 | 86 | 4 | 04f571708f2487b0dbd70ee507de6bf75be5f5d9 | |
| ToppCell | medial-2-Hematologic-Myeloid_Dendritic_Type_2|2 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 3.81e-05 | 195 | 86 | 5 | 54a404ee1b97d0659fcffafb20d11f878ed453d4 | |
| ToppCell | medial-Hematologic-Myeloid_Dendritic_Type_2|medial / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 3.81e-05 | 195 | 86 | 5 | c0d1ecb378bb482a8e08d7065fcca07a65687dac | |
| ToppCell | Children_(3_yrs)-Immune-monocyte-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 3.81e-05 | 195 | 86 | 5 | 81a28289eda1a8a1a31b7357106f64ac5000e172 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Immune-Myeloid-Monocytic-Monocyte-derived_Cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 3.81e-05 | 195 | 86 | 5 | 62dc745e1aa3e2e58afa16c7bb2cf9b03d4e8105 | |
| ToppCell | medial-Hematologic-Myeloid_Dendritic_Type_2-2|medial / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 3.81e-05 | 195 | 86 | 5 | 35a5302b8b3e76bc92dc38979400c979f0e86550 | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_intercalated_cell-Cortical_Collecting_Duct_Intercalated_Cell_Type_A|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 3.81e-05 | 195 | 86 | 5 | f7d9adadd37209ce1a38e5d621607b9c9270fed8 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Immune-Myeloid-Macrophage_Dendritic|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 3.81e-05 | 195 | 86 | 5 | 34a9462f4e843f3065cc58c17ad71c1b5b836ae1 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Immune-Myeloid|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 3.90e-05 | 196 | 86 | 5 | 4370473693d2dd4a8c451a4c477eb79baa33ae12 | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal-Inh_GABAergic|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.90e-05 | 196 | 86 | 5 | 7af6c5147ac859353504d19727dbe24f63a29dd4 | |
| ToppCell | mild-low-quality_cells|mild / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 4.00e-05 | 197 | 86 | 5 | e4331969bd911d1ebb5453f40a7057297b5389b4 | |
| ToppCell | COVID-19-kidney-Macrophages|COVID-19 / Disease (COVID-19 only), tissue and cell type | 4.00e-05 | 197 | 86 | 5 | 3912301018d0863144dcfac8d1fa8adc081748d7 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Immune|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 4.00e-05 | 197 | 86 | 5 | c9b1f2ee7eb31a66af331c5aae29e1bbb5186f5a | |
| ToppCell | COVID-19-lung-Macrophage_LDB2hi_OSMRhi_YAP1hi|lung / Disease (COVID-19 only), tissue and cell type | 4.00e-05 | 197 | 86 | 5 | 3896729740d151f0eb845f1961c7b969bfbdd28d | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Myeloid-TAM-MG-TAM-MG_aging_sig-F|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 4.00e-05 | 197 | 86 | 5 | 50f994e0d4e69019ec92e164edf3e4e951333766 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Immune-Myeloid-Monocytic-Monocyte-derived_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 4.00e-05 | 197 | 86 | 5 | 826cc6baafab13e7ef5cfcf28cd79d0fbf3af38d | |
| ToppCell | Parenchymal-NucSeq-Immune_Myeloid-Macrophage_alveolar|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 4.09e-05 | 198 | 86 | 5 | e125eb8aa57c172e5518874da1bd25998292f5e2 | |
| ToppCell | Parenchymal-NucSeq-Immune_Myeloid-Macrophage_alveolar-Macro_alveolar|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 4.09e-05 | 198 | 86 | 5 | 0baeb8e2c199ff10bb5c829c523546af3c9227c1 | |
| ToppCell | Fetal_29-31_weeks-Immune|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 4.09e-05 | 198 | 86 | 5 | 5dff131356b8c22743bd27b2b21f86ee6e4a0a0d | |
| ToppCell | 10x_5'_v1-Non-neoplastic-Myeloid-TAM-MG|10x_5'_v1 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 4.09e-05 | 198 | 86 | 5 | 9aced8bdb56ee52866a0a9766a84336961bc4443 | |
| ToppCell | Control|World / disease group and sub_cluster of B and Plasma cells(res = 0.5) | 4.09e-05 | 198 | 86 | 5 | 73694b6109c1f6878b6b5997e434bbc3cec1dc70 | |
| ToppCell | distal-Hematologic-Classical_Monocyte-1|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 4.19e-05 | 199 | 86 | 5 | cd691f1c2493516d7553cc9a005f6e3b442bdbd5 | |
| ToppCell | Parenchymal-NucSeq-Immune_Myeloid-Mast_cell|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 4.29e-05 | 200 | 86 | 5 | 9156f8fd61a833891d2f7b7fadd693b81b1e2d5a | |
| ToppCell | Neuronal-Inhibitory|Neuronal / cells hierarchy compared to all cells using T-Statistic | 4.29e-05 | 200 | 86 | 5 | 9ff8647e2de0b538e15929dca88ebb20ff7ab043 | |
| ToppCell | Bronchial-NucSeq-Immune_Myeloid-Macrophage_alveolar|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 4.29e-05 | 200 | 86 | 5 | a443e475e7a10c26a6173d1af961de6219e0e567 | |
| ToppCell | Parenchymal-NucSeq-Immune_Myeloid-Mast_cell-Mast_cell|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 4.29e-05 | 200 | 86 | 5 | 566fe2e78e6f35399ec6aad5964f6d4d8ade82c6 | |
| ToppCell | Parenchymal-10x5prime-Immune_Myeloid-Mast_cell-Mast_cell|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 4.29e-05 | 200 | 86 | 5 | 8943278190f42016ee914e584d1b6b9aeaf7c73f | |
| ToppCell | Bronchial-NucSeq-Immune_Myeloid-Macrophage_alveolar-Macro_alveolar|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 4.29e-05 | 200 | 86 | 5 | ed785a6d08ca2b350dc3307b587eadfb2886d1f9 | |
| ToppCell | Parenchymal-10x5prime-Immune_Myeloid-Mast_cell|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 4.29e-05 | 200 | 86 | 5 | ea52df18400550b65de142d03b3b0963436e03d9 | |
| ToppCell | droplet-Heart-nan-3m-Hematologic-erythrocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.03e-05 | 45 | 86 | 3 | 8caef8096e4231e30465a4ac5ed20ac4248c51ea | |
| ToppCell | PBMC-Control-Myeloid-Classical_Monocyte-Classical_Monocyte-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 1.70e-04 | 143 | 86 | 4 | 4c5a5db46beb8f2f3c40e8ed95911fbfea61bae0 | |
| ToppCell | Smart-seq2-lymph_node_(Smart-seq2)-lymphocytic-T_lymphocytic-T_cell|lymph_node_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 2.04e-04 | 150 | 86 | 4 | c922dbb4c9c12ccf08bd5f6168b20606c605d052 | |
| ToppCell | VE-CD8-memory_CD4|VE / Condition, Cell_class and T cell subcluster | 2.14e-04 | 152 | 86 | 4 | 9401b7770c1bdc87eba25e82922f5dd1c4fa37ee | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_intercalated_cell-Cortical_Collecting_Duct_Intercalated_Cell_Type_A|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 2.14e-04 | 152 | 86 | 4 | 9391b46a441cf031665df1d142e3f65e98675eeb | |
| ToppCell | COVID-19-Heart-Adipocyte|COVID-19 / Disease (COVID-19 only), tissue and cell type | 2.20e-04 | 153 | 86 | 4 | 93958bd9c951222ba5b740d1cb83fd5d78a10e1e | |
| ToppCell | facs-Aorta-Heart-18m-Mesenchymal-fibrocyte|Aorta / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.37e-04 | 156 | 86 | 4 | 5b56217336771baf57d791efcb4e206c6aea83b1 | |
| ToppCell | COVID-19-Mast_cells-Mast_cells|COVID-19 / group, cell type (main and fine annotations) | 2.37e-04 | 156 | 86 | 4 | bc10b94673184ef384c6665b16a1209a8975a4f1 | |
| ToppCell | COVID-19-Mast_cells|COVID-19 / group, cell type (main and fine annotations) | 2.37e-04 | 156 | 86 | 4 | 159504d43421ee83b9ab484816333ae549c9c2fd | |
| ToppCell | droplet-Liver-Hepatocytes-24m-Myeloid|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.43e-04 | 157 | 86 | 4 | ec433d2fe827abdb647be4176c231b7052482b6f | |
| ToppCell | PND10-Immune-Immune_Myeloid-DC-cDC1-cDC1_mature|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.55e-04 | 159 | 86 | 4 | 807ee55fe0d3645fbfb98f641dd0a0555b847cf5 | |
| ToppCell | PND10-Immune-Immune_Myeloid-DC-cDC1|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.55e-04 | 159 | 86 | 4 | 7bb76324d2026d4bd348126cb169c8411f0d7145 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast-Adaptive_/_Maladaptive_/_Repairing_Fibroblast|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.67e-04 | 161 | 86 | 4 | 4f25eeabb841b0b9204cdd4e71d5e131e7868184 | |
| ToppCell | PND03-Immune-Immune_Myeloid-DC|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.67e-04 | 161 | 86 | 4 | f50e91f8363f20bb7c565aaca4d4961d3fe4b5b5 | |
| ToppCell | ASK428-Immune-Mast_cell|ASK428 / Donor, Lineage and Cell class of Lung cells from Dropseq | 2.80e-04 | 163 | 86 | 4 | 569ca0e8ce307f258910b0c75c498009a9651e6e | |
| ToppCell | P07-Endothelial-lymphatic_endothelial_cell|P07 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 2.80e-04 | 163 | 86 | 4 | 5cbab3d03bb1af9391ecad635d6eea1dd42c1337 | |
| ToppCell | COVID-mono3|COVID / Condition, Cell_class and T cell subcluster | 2.80e-04 | 163 | 86 | 4 | 6ab4cbcd411b40920b81162c0f4b03ea67408f52 | |
| ToppCell | P07-Endothelial-lymphatic_endothelial_cell-endothelial_cell_of_lymphatic_vessel|P07 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 2.80e-04 | 163 | 86 | 4 | 322ba94c3ec1e1859c2e2195ecb3f7dab8d190f6 | |
| ToppCell | COVID-mono3-|COVID / Condition, Cell_class and T cell subcluster | 2.80e-04 | 163 | 86 | 4 | 26661c7a3a0a449ed32d4b3b28fc2fc0b237025d | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22-Myeloid-Monocytic-Nonclassical_Monocyte|Severe-critical_progression_d12-22 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.86e-04 | 164 | 86 | 4 | 17d5b8bb7c015cf9f0d6e578a0d212eada39cb93 | |
| ToppCell | facs-Heart-RA-24m-Lymphocytic-B_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.93e-04 | 165 | 86 | 4 | 36415924d05373e9dd3665be599f4f3f40bf0497 | |
| ToppCell | facs-Heart-RA-24m-Lymphocytic-B_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.93e-04 | 165 | 86 | 4 | 56310fddd3d8e4afdfde066d26cee9747e5b8c6a | |
| ToppCell | facs-Kidney-nan-3m-Lymphocytic-B_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.00e-04 | 166 | 86 | 4 | 6a948aefd283a2572da37b59dbc142b6e686b024 | |
| ToppCell | facs-Kidney-nan-3m-Lymphocytic-B_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.00e-04 | 166 | 86 | 4 | 8d0c4eb90a2c006f96ae61d3d94c96fb64bc0c4d | |
| ToppCell | 10x5'-Liver-Hematopoietic_progenitors|Liver / Manually curated celltypes from each tissue | 3.00e-04 | 166 | 86 | 4 | ae967570248cf86ca3ddf55e33bcbb3e4e3684bc | |
| ToppCell | 10x5'-Liver-Hematopoietic_progenitors-Cycling_pre-Myeloid-2|Liver / Manually curated celltypes from each tissue | 3.00e-04 | 166 | 86 | 4 | a176e87aa6eec81d1fb79a028f759182d11b567d | |
| ToppCell | Tracheal-10x3prime_v2-Immune_Myeloid-Macrophage_other-Macrophage_intermediate|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 3.09e-04 | 68 | 86 | 3 | f1cbc6d72489272c1eb6200f64b8b6444719acda | |
| ToppCell | 5'-GW_trimst-2-LymphNode-Hematopoietic-B_cells-Pro-B|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.14e-04 | 168 | 86 | 4 | c833e3311af2582787d3ff2ad59d802fff865f8f | |
| ToppCell | PND07-Immune-Immune_Lymphocytic_T/NK-Lymphocytic_B-B-B_mature|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.14e-04 | 168 | 86 | 4 | 943687a33fffd7e19d906b9dd385a126bcea109a | |
| Drug | 15d-PGJ2; Up 200; 10uM; PC3; HG-U133A | 8.24e-06 | 194 | 85 | 7 | 446_UP | |
| Drug | Trichostatin A, from Streptomyces sp.; Up 200; 0.1uM; HL60; HT_HG-U133A | 8.52e-06 | 195 | 85 | 7 | 2566_UP | |
| Drug | Merbromin [129-16-8]; Up 200; 5uM; HL60; HT_HG-U133A | 9.41e-06 | 198 | 85 | 7 | 2577_UP | |
| Drug | Pridinol methanesulfonate salt [6856-31-1]; Up 200; 10.2uM; HL60; HT_HG-U133A | 9.41e-06 | 198 | 85 | 7 | 2715_UP | |
| Drug | 5-aza-2′-deoxycytidine; Down 200; 0.1uM; MCF7; HT_HG-U133A_EA | 9.73e-06 | 199 | 85 | 7 | 920_DN | |
| Drug | Lithocholic acid [434-13-9]; Down 200; 10.6uM; MCF7; HT_HG-U133A | 9.11e-05 | 195 | 85 | 6 | 4373_DN | |
| Drug | rapamycin, Streptomyces hygroscepicus; Up 200; 0.1uM; MCF7; HT_HG-U133A | 9.37e-05 | 196 | 85 | 6 | 5975_UP | |
| Drug | Mephenytoin [50-12-4]; Up 200; 18.4uM; HL60; HT_HG-U133A | 9.37e-05 | 196 | 85 | 6 | 6158_UP | |
| Drug | 2-propylpentanoic acid; Up 200; 500uM; HL60; HT_HG-U133A | 9.37e-05 | 196 | 85 | 6 | 1181_UP | |
| Drug | Hexamethonium dibromide dihydrate [55-97-0]; Up 200; 10uM; MCF7; HT_HG-U133A | 9.37e-05 | 196 | 85 | 6 | 4965_UP | |
| Drug | Canrenoic acid potassium salt [2181-04-6]; Down 200; 10uM; PC3; HT_HG-U133A | 9.37e-05 | 196 | 85 | 6 | 2065_DN | |
| Drug | Cefamandole sodium salt [30034-03-8]; Up 200; 8.2uM; MCF7; HT_HG-U133A | 9.37e-05 | 196 | 85 | 6 | 4718_UP | |
| Drug | aspirin, USP; Up 200; 100uM; MCF7; HT_HG-U133A | 9.64e-05 | 197 | 85 | 6 | 6964_UP | |
| Drug | Serotonin hydrochloride [153-98-0]; Up 200; 18.8uM; MCF7; HT_HG-U133A | 9.64e-05 | 197 | 85 | 6 | 3311_UP | |
| Drug | Doxepin hydrochloride [1229-29-4]; Up 200; 12.6uM; HL60; HT_HG-U133A | 9.64e-05 | 197 | 85 | 6 | 2384_UP | |
| Drug | clozapine; Up 200; 10uM; MCF7; HT_HG-U133A | 9.64e-05 | 197 | 85 | 6 | 6947_UP | |
| Drug | 0198306-0000 [212631-61-3]; Down 200; 10uM; PC3; HT_HG-U133A | 9.64e-05 | 197 | 85 | 6 | 7069_DN | |
| Drug | Chlorhexidine [55-56-1]; Up 200; 8uM; MCF7; HT_HG-U133A | 9.64e-05 | 197 | 85 | 6 | 5403_UP | |
| Drug | Mimosine [500-44-7]; Down 200; 20.2uM; MCF7; HT_HG-U133A | 9.64e-05 | 197 | 85 | 6 | 2638_DN | |
| Drug | Alclometasone dipropionate [667634-13-2]; Down 200; 7.6uM; HL60; HT_HG-U133A | 9.64e-05 | 197 | 85 | 6 | 2532_DN | |
| Drug | Clenbuterol hydrochloride [21898-19-1]; Down 200; 12.8uM; MCF7; HT_HG-U133A | 9.64e-05 | 197 | 85 | 6 | 3228_DN | |
| Drug | Norethynodrel [68-23-5]; Down 200; 13.4uM; PC3; HT_HG-U133A | 9.91e-05 | 198 | 85 | 6 | 1818_DN | |
| Drug | Glutethimide, para-amino [125-84-8]; Up 200; 17.2uM; MCF7; HT_HG-U133A | 9.91e-05 | 198 | 85 | 6 | 7421_UP | |
| Drug | Oleandomycin phosphate [7060-74-4]; Down 200; 5uM; PC3; HT_HG-U133A | 1.02e-04 | 199 | 85 | 6 | 4615_DN | |
| Drug | Ungerine nitrate; Up 200; 10.2uM; MCF7; HT_HG-U133A | 1.02e-04 | 199 | 85 | 6 | 6076_UP | |
| Drug | Alfadolone acetate [23930-37-2]; Down 200; 10.2uM; PC3; HT_HG-U133A | 1.02e-04 | 199 | 85 | 6 | 7262_DN | |
| Drug | Clebopride maleate [84370-95-6]; Down 200; 8.2uM; HL60; HT_HG-U133A | 1.02e-04 | 199 | 85 | 6 | 1292_DN | |
| Drug | Dyclonine hydrochloride [536-43-6]; Up 200; 12.2uM; HL60; HT_HG-U133A | 1.02e-04 | 199 | 85 | 6 | 2392_UP | |
| Drug | Dimaprit dihydrochloride [23256-33-9]; Up 200; 17uM; MCF7; HT_HG-U133A | 1.05e-04 | 200 | 85 | 6 | 7480_UP | |
| Disease | Menke-Hennekam syndrome | 7.26e-06 | 2 | 80 | 2 | cv:C5681632 | |
| Disease | Rubinstein-Taybi syndrome (implicated_via_orthology) | 7.26e-06 | 2 | 80 | 2 | DOID:1933 (implicated_via_orthology) | |
| Disease | Ectodermal dysplasia 10B, hypohidrotic/hair/tooth type, autosomal recessive | 7.26e-06 | 2 | 80 | 2 | cv:C3887494 | |
| Disease | Rubinstein-Taybi syndrome | 7.26e-06 | 2 | 80 | 2 | cv:C0035934 | |
| Disease | RUBINSTEIN-TAYBI SYNDROME 1 | 7.26e-06 | 2 | 80 | 2 | C4551859 | |
| Disease | Autosomal hypohidrotic ectodermal dysplasia | 7.26e-06 | 2 | 80 | 2 | cv:CN118829 | |
| Disease | RUBINSTEIN-TAYBI SYNDROME 1 | 7.26e-06 | 2 | 80 | 2 | 180849 | |
| Disease | Rubinstein-Taybi syndrome due to CREBBP mutations | 7.26e-06 | 2 | 80 | 2 | cv:C4551859 | |
| Disease | ECTODERMAL DYSPLASIA 10B, HYPOHIDROTIC/HAIR/TOOTH TYPE, AUTOSOMAL RECESSIVE | 7.26e-06 | 2 | 80 | 2 | 224900 | |
| Disease | Ectodermal Dysplasia 3, Anhidrotic | 7.26e-06 | 2 | 80 | 2 | C1720965 | |
| Disease | Ectodermal dysplasia 10A, hypohidrotic/hair/nail type, autosomal dominant | 7.26e-06 | 2 | 80 | 2 | cv:C3888065 | |
| Disease | Rubinstein-Taybi syndrome (is_implicated_in) | 7.26e-06 | 2 | 80 | 2 | DOID:1933 (is_implicated_in) | |
| Disease | ECTODERMAL DYSPLASIA 10A, HYPOHIDROTIC/HAIR/NAIL TYPE, AUTOSOMAL DOMINANT | 7.26e-06 | 2 | 80 | 2 | 129490 | |
| Disease | Rubinstein-Taybi Syndrome | 7.26e-06 | 2 | 80 | 2 | C0035934 | |
| Disease | Hypohidrotic ectodermal dysplasia | 2.17e-05 | 3 | 80 | 2 | cv:C5848103 | |
| Disease | Autosomal recessive hypohidrotic ectodermal dysplasia syndrome | 2.17e-05 | 3 | 80 | 2 | cv:C0406702 | |
| Disease | response to thiazide, QT interval | 2.17e-05 | 3 | 80 | 2 | EFO_0004682, EFO_0007981 | |
| Disease | Ectodermal Dysplasia, Hypohidrotic, Autosomal Recessive | 2.17e-05 | 3 | 80 | 2 | C0406702 | |
| Disease | hypohidrotic ectodermal dysplasia (implicated_via_orthology) | 4.34e-05 | 4 | 80 | 2 | DOID:14793 (implicated_via_orthology) | |
| Disease | Autosomal dominant hypohidrotic ectodermal dysplasia syndrome (disorder) | 4.34e-05 | 4 | 80 | 2 | C0265331 | |
| Disease | coronary aneurysm | 1.18e-04 | 35 | 80 | 3 | EFO_1000881 | |
| Disease | Squamous cell carcinoma of esophagus | 1.32e-04 | 95 | 80 | 4 | C0279626 | |
| Disease | psoriasis (implicated_via_orthology) | 1.51e-04 | 7 | 80 | 2 | DOID:8893 (implicated_via_orthology) | |
| Disease | limb-girdle muscular dystrophy (implicated_via_orthology) | 1.51e-04 | 7 | 80 | 2 | DOID:11724 (implicated_via_orthology) | |
| Disease | Adenoid Cystic Carcinoma | 1.61e-04 | 100 | 80 | 4 | C0010606 | |
| Disease | Carcinoma, Transitional Cell | 1.90e-04 | 41 | 80 | 3 | C0007138 | |
| Disease | Adenocarcinoma of lung (disorder) | 2.48e-04 | 206 | 80 | 5 | C0152013 | |
| Disease | hair morphology measurement | 4.31e-04 | 54 | 80 | 3 | EFO_0007821 | |
| Disease | Diffuse Large B-Cell Lymphoma | 4.55e-04 | 55 | 80 | 3 | C0079744 | |
| Disease | Headache | 7.10e-04 | 64 | 80 | 3 | HP_0002315 | |
| Disease | Autistic Disorder | 7.30e-04 | 261 | 80 | 5 | C0004352 | |
| Disease | pro-hydroxy-pro measurement | 8.50e-04 | 16 | 80 | 2 | EFO_0021132 | |
| Disease | heart disease (biomarker_via_orthology) | 9.61e-04 | 17 | 80 | 2 | DOID:114 (biomarker_via_orthology) | |
| Disease | Alzheimer disease, psychotic symptoms | 9.61e-04 | 17 | 80 | 2 | EFO_0005940, MONDO_0004975 | |
| Disease | Leukemia, Myelocytic, Acute | 1.28e-03 | 173 | 80 | 4 | C0023467 | |
| Disease | citrulline measurement | 1.34e-03 | 20 | 80 | 2 | EFO_0009777 | |
| Disease | Intellectual Disability | 1.37e-03 | 447 | 80 | 6 | C3714756 | |
| Disease | calcium measurement | 1.59e-03 | 628 | 80 | 7 | EFO_0004838 | |
| Disease | Renal glomerular disease | 1.77e-03 | 23 | 80 | 2 | C0268731 | |
| Disease | Glomerulopathy Assessment | 1.77e-03 | 23 | 80 | 2 | C4521256 | |
| Disease | obsessive-compulsive disorder, attention deficit hyperactivity disorder, Tourette syndrome, unipolar depression, bipolar disorder, autism spectrum disorder, schizophrenia, anorexia nervosa | 2.17e-03 | 200 | 80 | 4 | EFO_0003756, EFO_0003761, EFO_0003888, EFO_0004242, EFO_0004895, MONDO_0004985, MONDO_0005090, MONDO_0005351 | |
| Disease | triacylglycerol 56:5 measurement | 2.26e-03 | 26 | 80 | 2 | EFO_0010432 | |
| Disease | schizophrenia, intelligence, self reported educational attainment | 2.52e-03 | 346 | 80 | 5 | EFO_0004337, EFO_0004784, MONDO_0005090 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| MGQKKTMGTERSRGG | 1 | A8MZ25 | |
| MAIFFTKGTTGAPKM | 221 | Q6P461 | |
| KPGMKARFVDSGEMA | 1336 | Q09472 | |
| LMMKGEGSRKGSFFK | 441 | Q9P2I0 | |
| VKPGMKSRFVDSGEM | 1371 | Q92793 | |
| MKKFSRMPKSEGGSG | 1 | Q9NSY1 | |
| QSGKGDMVEMATRFG | 221 | Q9Y3T6 | |
| GMMRTGGTIKGSKVT | 56 | Q9NTZ6 | |
| MEGDVSSKDKMGKGV | 1816 | Q96L73 | |
| ETGCKIMVRGKGSMR | 116 | Q96PU8 | |
| TSAKVMMEGGRSKGF | 321 | P11940 | |
| GAMTSMVCKVGKDSF | 66 | Q9H477 | |
| GVGGMAKEATMKGSS | 686 | Q14126 | |
| AMFSGKMPTKRDSQG | 31 | Q4G0X4 | |
| RMEKSGKGGMSGGRS | 691 | Q2KJY2 | |
| FGLKRDEIGGMTDGM | 381 | Q9UNE0 | |
| LCGIMDGTKGMTRSK | 386 | Q8IYD8 | |
| GGTVMGESGMKTVED | 776 | P26006 | |
| FTGFSKDRMMQKPGS | 76 | Q8NHU0 | |
| FKASSTKGRMVMSRG | 1096 | Q9H6R4 | |
| MLGGSAGRLKMSSSG | 1 | P28356 | |
| MVLGKGSFGKVMLSE | 346 | P05771 | |
| EAIMFKGLGGMSSKR | 511 | Q9Y2J8 | |
| MVSAAGLSGDGKMRG | 1 | Q6PEW0 | |
| KDTSMGNASSGMVRK | 166 | O15541 | |
| LGVKTSMGDRDMGLF | 396 | Q96M63 | |
| MTGFELTEGVKTSGM | 651 | Q02413 | |
| TSAKVMMEGGRSKGF | 321 | Q9H361 | |
| TFGTKSRVGMGGMEA | 296 | P54886 | |
| SRVGMGGMEAKVKAA | 301 | P54886 | |
| AYVMEKAGGMATTGK | 286 | P09467 | |
| TSMSKMFVKGAPEGV | 506 | P16615 | |
| FTGFSKDRMMQKPGS | 76 | Q5HYN5 | |
| FTGFSKDRMMQKPGS | 76 | P0DMV2 | |
| ARFGSAMEKSGKMDV | 1221 | B1AJZ9 | |
| MGKTNLDEFAMGSGS | 116 | Q9H0R6 | |
| SVMMFKKGSFEIGGT | 311 | Q53EU6 | |
| VGFSSDKKMGGDDVM | 146 | Q9P0K9 | |
| TGMAALDSKASGKMG | 106 | P43003 | |
| GRMPSIAKDVFTKMG | 1096 | Q9P0X4 | |
| TSTFKEMRGAMEGKQ | 246 | Q96A23 | |
| FTGFSKDRMMQKPGS | 76 | Q5DJT8 | |
| EGGTATTMVSKDIGM | 1021 | Q13873 | |
| SLSMRKSGAMKKGGI | 166 | O60238 | |
| MSVGAMKKGVGRAVG | 1 | Q99705 | |
| FTGFSKDRMMQKPGS | 76 | P0DMV1 | |
| MGLRTTKQMGRGTKA | 1 | Q8WWZ3 | |
| ARKGSGMMSKSDNFG | 51 | P22676 | |
| MEFSGRDASGKRVMG | 1601 | P49327 | |
| MAEMGSKGVTAGKIA | 1 | O00499 | |
| KGKITGGGMVDVMCS | 461 | Q6ZTR5 | |
| GKSAGTQGDMEKADM | 1301 | Q96JN8 | |
| SMGKADFMGRTFAKP | 1041 | Q9HC10 | |
| KSKFLGMSIGVTMVG | 536 | Q9BXB4 | |
| RMSSLGAGVTSAKKM | 311 | Q92833 | |
| SSGVTGAMDMAKGAV | 126 | Q96Q06 | |
| GGNAMSFMGKGVTKS | 1311 | Q86VV8 | |
| MKSAIGEGMTRKDHG | 396 | P15313 | |
| GGSGGITMAARMKRK | 51 | Q9Y6N5 | |
| SVSGGDGKMDTMIGD | 66 | Q9HCJ0 | |
| PMKRAGTTGSARGMA | 521 | Q9Y2J0 | |
| GLKRTTDMMFGGKQV | 381 | Q96HN2 | |
| AFVTMTGGFRRGKKM | 326 | P04053 | |
| IKGGMKGFQSFMVSD | 1196 | Q9P212 | |
| MSGSMDKGTLGSGSK | 646 | O14802 | |
| MATEGGGKEMNEIKT | 1 | Q8TBZ3 | |
| IGSTMSGRKGTDDSM | 106 | O00422 | |
| KGMGGAMDLVSSAKT | 421 | P55809 | |
| LEAEGMRGRKSGGSM | 3071 | Q6ZRS2 | |
| IMISDFGLSKMEGKG | 161 | Q8IU85 | |
| FGLSKMEGKGDVMST | 166 | Q8IU85 | |
| KRMGMSFGLESGKCS | 316 | Q14188 | |
| KAKTTGMGAIYGMAQ | 516 | O95470 | |
| AAGGKGGKNTMMRSH | 741 | Q9UM73 | |
| MKGEFSRGLGLEMAS | 691 | Q70JA7 | |
| VGMSRDAVKFGRMSK | 136 | P35398 | |
| DVMMGTFTKSFGASG | 371 | O15270 | |
| LLMGKSGSGKTSMRS | 11 | Q7L523 | |
| GKSPFRESSGDGMKM | 756 | O15014 | |
| MTSGGDAAMFRDGKE | 1931 | Q6ZS81 | |
| EQSGTMTGGGSKVMK | 746 | Q9NTJ3 | |
| SATKGTLGGMFGMLK | 311 | P08240 | |
| MGKSGSGKTSMRSII | 46 | Q5VZM2 | |
| GVALGMAGSAMSSKF | 11 | P41221 | |
| GEGEGSMTKEEFTKM | 111 | Q9UNH7 | |
| FMGVESGHMKEGTKV | 1091 | P11137 | |
| EAKMMKAGGTEIGKT | 41 | O95218 | |
| GSFGEGLTMKKQSGM | 646 | Q9ULT0 | |
| GFGKESERSMTMTKS | 301 | Q03167 | |
| EDTSSGSKGYMKVSM | 306 | Q9NZM1 | |
| GSKGYMKVSMFVLGT | 311 | Q9NZM1 |